7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Tailored NIR‐II Lanthanide Luminescent Nanocrystals for Improved Biomedical Application

      1 , 2 , 1 , 1
      Advanced Optical Materials
      Wiley

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recently, in vivo optical imaging in the second‐near‐infrared window (NIR‐II, 1000–1700 nm) that allows high spatiotemporal resolution and imaging depth due to reduced photon scattering and weak auto‐fluorescence has drawn more and more attention. Among various NIR‐II optical probes, lanthanide‐doped nanoparticles show several great advantages including abundant energy levels transitions for multi‐emissions, ultra‐stable emissions for long‐term detection, and long luminescence lifetime for background‐free imaging. These merits have inspired researchers to make great efforts to develop superior lanthanide‐doped nanoparticles for in vivo bio‐imaging and bio‐sensing. In this review, NIR‐II luminescent emissions and absorption spectra of several lanthanide ions are outlined, and the recent advances in designing NIR‐II lanthanide‐doped nanocrystals with optimized quantum yields are summarized. Then their significant concerns for in vivo imaging and sensing including assembly and disassembly, clearance, and responsiveness of lanthanide‐based nanoparticles are discussed. Major challenges and future opportunities in the NIR‐II bio‐imaging using lanthanide nanocrystals are finally proposed to direct new solutions and interdisciplinary research.

          Related collections

          Most cited references134

          • Record: found
          • Abstract: not found
          • Article: not found

          Analysis of nanoparticle delivery to tumours

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Engineering precision nanoparticles for drug delivery

            In recent years, the development of nanoparticles has expanded into a broad range of clinical applications. Nanoparticles have been developed to overcome the limitations of free therapeutics and navigate biological barriers — systemic, microenvironmental and cellular — that are heterogeneous across patient populations and diseases. Overcoming this patient heterogeneity has also been accomplished through precision therapeutics, in which personalized interventions have enhanced therapeutic efficacy. However, nanoparticle development continues to focus on optimizing delivery platforms with a one-size-fits-all solution. As lipid-based, polymeric and inorganic nanoparticles are engineered in increasingly specified ways, they can begin to be optimized for drug delivery in a more personalized manner, entering the era of precision medicine. In this Review, we discuss advanced nanoparticle designs utilized in both non-personalized and precision applications that could be applied to improve precision therapies. We focus on advances in nanoparticle design that overcome heterogeneous barriers to delivery, arguing that intelligent nanoparticle design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Principles of nanoparticle design for overcoming biological barriers to drug delivery.

              Biological barriers to drug transport prevent successful accumulation of nanotherapeutics specifically at diseased sites, limiting efficacious responses in disease processes ranging from cancer to inflammation. Although substantial research efforts have aimed to incorporate multiple functionalities and moieties within the overall nanoparticle design, many of these strategies fail to adequately address these barriers. Obstacles, such as nonspecific distribution and inadequate accumulation of therapeutics, remain formidable challenges to drug developers. A reimagining of conventional nanoparticles is needed to successfully negotiate these impediments to drug delivery. Site-specific delivery of therapeutics will remain a distant reality unless nanocarrier design takes into account the majority, if not all, of the biological barriers that a particle encounters upon intravenous administration. By successively addressing each of these barriers, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.
                Bookmark

                Author and article information

                Contributors
                Journal
                Advanced Optical Materials
                Advanced Optical Materials
                Wiley
                2195-1071
                2195-1071
                June 2023
                November 20 2022
                June 2023
                : 11
                : 11
                Affiliations
                [1 ] Department of Chemistry State Key Laboratory of Molecular Engineering of Polymers Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials Fudan University Shanghai 200433 China
                [2 ] Institute of Transdisciplinary Discoveries Medical School University of Pecs Pecs H‐7624 Hungary
                Article
                10.1002/adom.202202039
                3d05fd38-e386-4c87-8565-71f95be01a05
                © 2023

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article